BST: Biotechnology Assets, S.A. - Summary | Jitta

Biotechnology Assets, S.A.

ESP:BST

Price
€0.23
Loss Chance
54.1%
2.52JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
66 / 139
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (49)
Recent Business Performance (39)
Financial Strength (40)
Return to Shareholders (0)
Competitive Advantage (24)
Jitta Signs
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2024
Operating MarginDeclined
Recent Business PerformanceEarning decline 43.15% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.52
100.00%
3.85
136.81%
4.64
105.67%
Biotechnology
4.08
52.49%
3.33
100.00%
5.49
399.73%
COMPANY DESCRIPTION
Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administered as DNA vaccines; and CLICK’N CUT, a tool to obtain tag-less proteins in a one-step process based on intein affinity, as well as Zebrafish assays. The company is based in Cádiz, Spain.